Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan
Antibody Prostate Cancer Focused IHC
Prostate cancer remains the leading cancer among men in the United States with 238,590 newly diagnosed cases and 29,720 deaths in
2012. The number of new cases of prostate cancer has decreased by 1.9% per year from 2000 to 2009 and the number of deaths from prostate cancer has decreased significantly by 3.5% per year from 1994 to 2009.1 This has been achieved by advancements in detection, diagnosis, and treatment of the disease. Biocare Medical continues to be the leader in Antibody prostate cancer focused IHC by offering a full menu of innovative primary antibodies, antibody cocktails, Multiplex IHC™ and our newly released line of Supernova antibodies.
Antibody: Sox2 , Arginase-1 , Estrogen Receptor (ER), CDH17, SOX11, CD7, CD20, Catenin 14/Beta-Catenin, Calponin, c-erB-2 / HER2 , Cytokeratin 7, E-Cadherin, Estrogen Receptor (ER), Folate Receptor alpha, GCDFP-15, Ki-67, Mammaglobin, p53, p63, p40, Phospho-Histone H3 , Progesterone Receptor (PR), Progesterone Receptor (PR), PTEN, Androgen Receptor, AMACR (RM), c-Myc, Cytokeratin 5, Cytokeratin HMW, ERG
Disclaimer: Biozatix Indonesia adalah distributor yang menyediakan alat- alat laboratorium, alat kesehatan, serta reagensia ELISA kits, immunohistochemistry (IHC), antibody, reagensia deteksi immunohistochemistry, secondary antibody untuk ELISA dan immunohistochemistry, research grade chemical, western blot, HPLC colomn, alat patologi, HPV genotyping, Florescent in Situ Hybridization (FISH), alat core biopsy.